Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.

Neurology·2026
Same author

Progressive disability but survival advantage in anti-Hu/ANNA1 paraneoplastic neurological syndromes.

Journal of neurology·2026
Same author

Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Effect of Botulinum Toxin Injection Intervals on the Irreversibility of Targeted Muscle Paralysis: An Electromyographic Study.

Aesthetic surgery journal·2026
Same author

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants.

Annals of clinical and translational neurology·2026
Same author

Paramagnetic rim lesions on 7T MRI after autologous hematopoietic cell transplantation.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Related Experiment Video

Updated: May 15, 2026

Surgical Transplantation of Mouse Neural Stem Cells into the Spinal Cords of Mice Infected with Neurotropic Mouse Hepatitis Virus
08:33

Surgical Transplantation of Mouse Neural Stem Cells into the Spinal Cords of Mice Infected with Neurotropic Mouse Hepatitis Virus

Published on: July 10, 2011

Mesenchymal stem cell transplantation in multiple sclerosis.

Jeffrey A Cohen1

  • 1Mellen Center, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA.

Journal of the Neurological Sciences
|January 9, 2013
PubMed
Summary

Mesenchymal stem cells (MSCs) show promise for treating multiple sclerosis (MS) due to their repair and anti-inflammatory properties. Early studies suggest MSC transplantation is safe and well-tolerated in MS patients.

Keywords:
BMCNSEAEEDSSExpanded Disability Status ScaleFBSHGFIBMIRIFNILIVImmunomodulationMOGMRIMSMSCMultiple sclerosisNeuroprotectionRegenerationStem cell transplantationTNFαbone marrowcentral nervous systemexperimental autoimmune encephalomyelitisfetal bovine serumhMSC-CMhepatocyte growth factorhuman mesenchymal stem cell conditioned mediuminstant blood-mediated inflammatory reactioninterferoninterleukinintravenousmagnetic resonance imagingmesenchymal stem cellmultiple sclerosismyelin oligodendrocyte glycoproteintumor necrosis factor-alpha

More Related Videos

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury
10:56

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury

Published on: December 17, 2014

Related Experiment Videos

Last Updated: May 15, 2026

Surgical Transplantation of Mouse Neural Stem Cells into the Spinal Cords of Mice Infected with Neurotropic Mouse Hepatitis Virus
08:33

Surgical Transplantation of Mouse Neural Stem Cells into the Spinal Cords of Mice Infected with Neurotropic Mouse Hepatitis Virus

Published on: July 10, 2011

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury
10:56

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury

Published on: December 17, 2014

Area of Science:

  • Stem Cell Biology
  • Neuroimmunology
  • Regenerative Medicine

Background:

  • Mesenchymal stem cells (MSCs) are multipotent stem cells with immunomodulatory and tissue-repairing capabilities.
  • MSCs share similarities with pericytes and can differentiate into mesodermal lineages.
  • Their properties make them a potential therapeutic for inflammatory and degenerative conditions like multiple sclerosis (MS).

Purpose of the Study:

  • To evaluate the safety and tolerability of autologous, culture-expanded bone marrow-derived MSC transplantation in patients with MS.
  • To explore the potential of MSCs as a therapeutic strategy for MS.

Main Methods:

  • Formal studies involving autologous, culture-expanded, bone marrow-derived MSC transplantation in MS patients.
  • Monitoring for safety concerns and overall tolerability of the procedure.

Main Results:

  • Published experience with MSC transplantation in MS is modest but preliminary results are promising.
  • The procedure has been well-tolerated to date, with no significant safety concerns reported.
  • Initiation of formal studies by multiple research groups, including the authors.

Conclusions:

  • MSC transplantation is a potentially safe and well-tolerated therapeutic approach for MS.
  • Further rigorous studies are needed to definitively assess the efficacy of MSCs in MS treatment.
  • Addressing technical challenges will be crucial for future clinical applications of MSCs in MS.